易威生醫科技股份有限公司
易威生醫科技股份有限公司（Easywell Biomedicals, Inc.）及其子公司研發製造活性醫藥成份（API）與非處方藥（OTC）。開發包括止咳藥、抗尿失禁、乳癌輔助治療及抗憂鬱藥物。此外提供體溫計、醫療器材及健康產品。公司成立於 1998 年，總部位於台灣新竹。
今日下跌 2.05%，股價跌破短期均線。該股 RSI(6) 為 34.5，處於中性區間，短線無明顯超買超賣訊號。股價跌破5日、20日、60日、120日均線。KD 指標偏低（K=7.9），有反彈空間；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-11 | -37 | 0 | 0 | -37 |
| 08-10 | -20 | 0 | +1 | -20 |
| 08-07 | -24 | 0 | 0 | -24 |
| 08-06 | -9 | 0 | +4 | -9 |
| 08-05 | -56 | 0 | 0 | -56 |
| 08-04 | -26 | 0 | +4 | -26 |
| 08-03 | -43 | 0 | 0 | -43 |
| 07-31 | -57 | 0 | 0 | -58 |
| 07-30 | +53 | 0 | +8 | +61 |
| 07-29 | +93 | 0 | +16 | +93 |
| 07-28 | -296 | 0 | 0 | -298 |
| 07-27 | -22 | 0 | +8 | -21 |
| 07-24 | +66 | 0 | +2 | +67 |
| 07-23 | -58 | 0 | 0 | -58 |
| 07-22 | -21 | 0 | 0 | -21 |
| 07-21 | -13 | 0 | 0 | -13 |
| 07-20 | +23 | 0 | 0 | +23 |
| 07-17 | -64 | 0 | 0 | -64 |
| 07-16 | -16 | 0 | 0 | -16 |
| 07-15 | +94 | 0 | +2 | +95 |
| 07-14 | +29 | 0 | +1 | +28 |
| 07-13 | +14 | 0 | +1 | +14 |
| 07-09 | +3 | 0 | 0 | +3 |
| 07-08 | +36 | 0 | 0 | +36 |
| 07-07 | +38 | 0 | 0 | +38 |
| 07-06 | -29 | 0 | +1 | -29 |
| 07-03 | +39 | 0 | 0 | +39 |
| 07-02 | -14 | 0 | 0 | -14 |
| 07-01 | +53 | 0 | +1 | +53 |
| 06-30 | +22 | 0 | 0 | +22 |
| 06-29 | +59 | 0 | 0 | +59 |
| 06-26 | -44 | 0 | 0 | -44 |
| 06-25 | +35 | 0 | 0 | +35 |
| 06-24 | +21 | 0 | 0 | +21 |
| 06-23 | +22 | 0 | 0 | +22 |
| 06-22 | +34 | 0 | 0 | +33 |
| 06-18 | -10 | 0 | +2 | -9 |
| 06-17 | +42 | 0 | 0 | +40 |
| 06-16 | +2 | 0 | 0 | +1 |
| 06-15 | +9 | 0 | 0 | +9 |
| 06-12 | +8 | 0 | +2 | +9 |
| 06-11 | +5 | 0 | +2 | +4 |
| 06-10 | +19 | 0 | +4 | +19 |
| 06-09 | -21 | 0 | 0 | -21 |
| 06-08 | +3 | 0 | 0 | +3 |
| 06-05 | -24 | 0 | +2 | -24 |
| 06-04 | +63 | 0 | 0 | +63 |
| 06-03 | +35 | 0 | +2 | +36 |
| 06-02 | -57 | 0 | +1 | -56 |
| 06-01 | +37 | 0 | 0 | +35 |
| 05-29 | +46 | 0 | 0 | +46 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/04 | 8854 萬 | -11.6% | +240.4% |
| 2026/03 | 1.00 億 | +69.3% | +30.6% |
| 2026/02 | 5913 萬 | -23.6% | +38.6% |
| 2026/01 | 7745 萬 | +14.7% | +140.2% |
| 2025/12 | 6750 萬 | +3.8% | -1.3% |
| 2025/11 | 6501 萬 | +119.0% | +72.9% |
| 2025/10 | 2968 萬 | -61.3% | -37.7% |
| 2025/09 | 7665 萬 | +29.8% | +14.3% |
| 2025/08 | 5908 萬 | +52.6% | +13.5% |
| 2025/07 | 3870 萬 | -20.4% | -45.8% |
| 2025/06 | 4865 萬 | +40.6% | -20.7% |
| 2025/05 | 3460 萬 | - | -6.2% |